Key facts
- Notable investors include Sichuan Yizhan Capital Management, Amy Space, Jilin Zhongke Venture Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Shaoxing Meikele Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Shaoxing Meikele Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Shaoxing Meikele Biotechnology
Provider of sustainable biomaterials intended to revolutionize leather production with eco-friendly alternatives. The company offers quality mycelium fibers cultivated through advanced gene editing and renewable substrates, enabling fashion and manufacturing industries to access low-carbon, biodegradable, and customizable materials that closely mimic traditional leather while reducing environmental impact.
- Sector
- Materials and Resources
- HQ
- Beijing, China
- Founded
- 2022
- Ownership
- Privately Held (backing)
Shaoxing Meikele Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Shaoxing Meikele Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Shaoxing Meikele Biotechnology in its N-PORT filings yet. We sweep new filings monthly.